There are 171 resources available
Q&A
Presenter: Lillian Siu
Session: Proffered Paper session
Resources:
Webcast
Advancement of statistical methodology and its practical implementation in phase I trials
Presenter: Christina Yap
Session: Phase I trial methodology
Resources:
Slides
Webcast
Pharmacodynamic endpoints in FIH trials
Presenter: Udai Banerji
Session: Phase I trial methodology
Resources:
Slides
Webcast
Q&A
Presenter: Christina Yap
Session: Phase I trial methodology
Resources:
Webcast
Introduction
Presenter: Solange Peters
Session: Seagen - ADCs’ journey into clinical use - Key considerations for improved outcomes
Resources:
Webcast
An overview of current approaches utilizing ADCs
Presenter: Solange Peters
Session: Seagen - ADCs’ journey into clinical use - Key considerations for improved outcomes
Resources:
Webcast
New ADC targets on the horizon
Presenter: Antoine Hollebecque
Session: Seagen - ADCs’ journey into clinical use - Key considerations for improved outcomes
Resources:
Webcast
Leveraging immune stimulatory ADCs to target immune checkpoints
Presenter: Elena Garralda Cabanas
Session: Seagen - ADCs’ journey into clinical use - Key considerations for improved outcomes
Resources:
Webcast
Q&A and discussion
Presenter: Solange Peters
Session: Seagen - ADCs’ journey into clinical use - Key considerations for improved outcomes
Resources:
Webcast
Why is this important? Trials versus off-label use
Presenter: Hans Gelderblom
Session: Workshop in collaboration with ESMO YOC: Drug repurposing trials
Resources:
Slides
Webcast